🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study was a Phase 1 and pharmacologic open-labeled dose-escalation tri...
Status
Completed
Location
University of Alabama at Birmingham Comprehensive Cancer Center
Start Date
2010-10
Trial ID
NCT01209195
Treatments Being Tested
This study is a multi-center, randomized, double-blind, placebo-controlled,...
Status
Terminated
Location
Ironwood Cancer and Research Centers- Chandler
Start Date
2017-08-15
Trial ID
NCT03241810
Treatments Being Tested
To determine whether the combination of MM-121 plus paclitaxel is more effe...
Status
Completed
Location
Arizona Center for Cancer Care
Start Date
2011-10
Trial ID
NCT01447706
Treatments Being Tested
To demonstrate whether addition of MM-121 to paclitaxel is more effective t...
Status
Completed
Location
Universito of Birmingham atAlabama
Start Date
2011-08
Trial ID
NCT01421472
Treatments Being Tested
NRG1 gene fusions are extremely rare across solid tumours (estimate 0.3-0.5...
Status
Completed
Location
The Ottawa Hospital Cancer Centre
Start Date
2021-03-29
Trial ID
NCT04790695
Treatments Being Tested
Primary Objective: * To determine the maximum tolerated dose (MTD) and rec...
Status
Completed
Location
Investigational Site Number 840001
Start Date
2011-11
Trial ID
NCT01436565
Treatments Being Tested
The purpose of this study was to evaluate the safety and tolerability of es...
Status
Completed
Location
Multiple Locations
Start Date
2011-10
Trial ID
NCT01451632
Treatments Being Tested
A Phase 1-2 study of MM-121 in combination with standard therapy for non-sm...
Status
Completed
Location
Multiple Locations
Start Date
2010-02
Trial ID
NCT00994123
This study is an open-label, international, multi-center, Phase 2 study in ...
Status
Terminated
Location
University of Alabama at Birmingham
Start Date
2020-09-29
Trial ID
NCT04383210
Treatments Being Tested
To evaluate the safety and tolerability of escalating doses of MM-121 + cer...
Status
Completed
Location
Multiple Locations
Start Date
2011-10
Trial ID
NCT01447225
Treatments Being Tested